Episurf Medical AB (publ) Price, Forecast, Insider, Ratings, Fundamentals & Signals

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Germany, the United Kingdom, and internationally. It offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for the treatment of elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. The company also provides Episealer Talus for osteochondral lesions of the talar dome of the ankle joint; Epiguide, a surgical drill guide; and Epiguide MOS, a surgical drill guide, which is designed for use in mosaicplasty surgery for treatment of cartilage and deep underlying bone defects in the knee joint. In addition, it offers µiFidelity, an order management system, for placing and following up on order, uploading MRI scans, and consult patient's damage marking report. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.